Patent · US Active

Heterocyclic compounds as CCR1 receptor antagonists

US8927550B2 · kind B2 · utility

3Cited by

36References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Brian Nicholas Cook · Danbury, US
Daniel Kuzmich · Clovis, US

Key dates

Filing date	Oct 21, 2010
Grant date	Jan 6, 2015
Priority date	—
Expiry date	Jan 24, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are CCR1 receptor antagonists of the formula (I) wherein Ar1, Ar2, R1-R3, X and L are disclosed herein. Also disclosed are compositions, methods of making and using compounds of the formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.